RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 30, 2023--Evecxia Therapeutics, Inc., the leader in serotonin synthesis amplification to treat neuropsychiatric disorders, today announced the appointments of Allan L. Shaw and Elliot Ehrich, MD to its Board of Directors, bringing with them ...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Oct 30, 2023--<a ...
PRINCETON, N.J.--(BUSINESS WIRE)--Oct 30, 2023--<a ...
IRVING, Texas--(BUSINESS WIRE)--Oct 30, 2023--<a ...
DARMSTADT, Germany--(BUSINESS WIRE)--Oct 30, 2023--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldwide (ex-China) to ...
LUGANO, Switzerland & OSAKA, Japan--(BUSINESS WIRE)--Oct 30, 2023--<a ...
